Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 118 publications
Understanding of Prognosis and Estimation of Mortality in Ambulatory Patients With Heart Failure.
Journal: JAMA network open
Published: March 03, 2026
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.
Journal: Journal of the American College of Cardiology
Published: January 14, 2025
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50.
Journal: American heart journal
Published: February 22, 2024
Cardiac Magnetic Resonance, Electromechanical Activation, Kidney Function, and Natriuretic Peptides in Cardiac Resynchronization Therapy Upgrades.
Journal: Journal of cardiovascular development and disease
Published: August 01, 2023
Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
Journal: Circulation. Heart failure
Published: June 20, 2023
Beta-blocker use and mortality among patients with systolic heart failure and pacemaker rhythm.
Journal: ESC heart failure
Published: October 10, 2022
Sudden Cardiac Death in Heart Failure: A 20-Year Perspective From a Mediterranean Cohort.
Journal: Journal of cardiac failure
Published: July 15, 2022
Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter-Defibrillator Generator Changes.
Journal: Journal of the American Heart Association
Published: June 29, 2022
Implantable Cardioverter-Defibrillator Therapy in the Contemporary Era of Heart Failure Therapeutics.
Journal: JACC. Clinical electrophysiology
Published: June 09, 2022
Impact of SGLT2 Inhibitors on Serum Sodium in Heart Failure With Reduced Ejection Fraction.
Journal: JACC. Heart failure
Published: February 15, 2022
Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.
Journal: European journal of heart failure
Published: February 02, 2022
Last Updated: 09/26/2026